Organization | Hopital Antoine Beclere

Hopital Antoine Beclere Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Clamart France (1982)

Organization Overview

First Clinical Trial

1998

NCT00593801

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Hopital Antoine Beclere service de Medecine Interne Clamart France | Hospital Antoine-Béclère

Active Ingredients

Drugs in Phase 4 Trials (2)

follitropin alfa (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Phase 3 Trials (1)

interferon alpha-2b (Intron-A) (1 trial)

Drugs in Other Trials (5)

bifidobacterium longum (1 trial)

darbepoetin beta (1 trial)

lactobacillus helveticus (1 trial)

lactococcus lactis (1 trial)

Streptococcus thermophilus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

HIV Infections (Phase 3)

Polycystic Ovary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 8